CORT Q4 2025 Earnings — Corcept Therapeutics Incorporated Revenue & Financial Results | Market Cap Arena

CORTCorcept Therapeutics Incorporated

$4B

Q4 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$202M+11.1% YoY

Gross Profit

$200M98.7% margin

Operating Income

$4M2.2% margin

Net Income

$24M12.0% margin

EPS (Diluted)

$0.20

QoQ Revenue Growth

-2.7%

Cash Flow

Operating Cash Flow

$38M

Free Cash Flow

$38M

Stock-Based Comp.

-$64M

Balance Sheet

Total Assets

$837M

Total Liabilities

$189M

Stockholders' Equity

$648M

Cash & Equivalents

$120M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$202M	$182M	+11.1%
Gross Profit	$200M	$179M	+11.5%
Operating Income	$4M	$25M	-82.2%
Net Income	$24M	$30M	-20.1%